Abstract:Objective To investigate mutation status of isocitrate dehydrogenase (IDH) 1 and IDH2 genes in Chinese patients with gliomas in correlation with clinicopathological characteristics.Methods Formalin-fixed and paraffin-embedded (FFPE) tissue samples of 234 gliomas were collected including the matched blood samples in 30 patients.DNA was extracted,followed by PCR-Sanger sequencing to detect IDH1 and IDH2 gene mutations.Immunohistochemistry was performed using mutation-specific antibody recognizing IDH1R132H mutation.Immunostains for p53 and epidermal growth factor receptor (EGFR) were also performed.Oligodendroglial tumors with IDH mutation were double stained with IDH1R132H and GFAP by immunofluorescence to investigate the location of IDH1 R132H expression.Results (1) By IDH1 heterozygous somatic mutation analysis,Arg132His (c:G395A) was found in 31.6％ (74 of 234) of the cases.IDH mutations were more frequent in oligoastrocytomas (9/13),anaplastic oligoastrocytomas (7/11),oligodendrogliomas (18/26,69.2％),anaplastic oligodendrogliomas (8/10),and less frequent in diffuse astrocytomas (17/47,36.2％),anaplastic astrocytomas (5/18),and glioblastomas (10/69,14.5％).The mutation rate inversely correlated with the tumor grade in a linear fashion in astrocytic tumors (P =0.007).Primary glioblastomas were characterized by a lower frequency of mutations than secondary glioblastomas (5/55 vs.5/14,P =0.036); IDH mutation was not detected in pilocytic astrocytoma and ependymoma.No IDH2 mutation was identified in this study cohort.(2) Immunohistochemistry of IDH1R132H demonstrated a strong cytoplasmic staining in 80 cases,which was highly correlated with IDH mutation status (P =0.001).IDH1R132H was highly specific to tumor cells.(3) p53 immunostain was significantly correlated the IDH mutation in diffuse astrocytoma,anaplastic astrocytoma and secondary glioblastomas (P =0.007,0.026,0.038 respectively).(4) No correlation between EGFR and IDH mutation was found.Conclusions High prevalence of IDH heterozygous somatic mutation occurs in the earlier stage of gliomas,which can be detected by mutation-specific antibody IDH1R132H.Furthermore,evaluation of p53 and EGFR expression combined with IDH mutation analysis may significantly aid in the diagnosis and differential diagnoses of gliomas in Chinese patients.

The significance of IDH1 mutations in tumor-associated seizure in 60 Chinese patients with low-grade gliomas.

IDH1 mutation is associated with a higher preoperative seizure incidence in low-grade glioma: A systematic review and meta-analysis

IDH Mutations but Not TERTp Mutations Are Associated with Seizures in Lower-Grade Gliomas.

An analysis of 170 glioma patients and systematic review to investigate the association between IDH-1 mutations and preoperative glioma-related epilepsy

New-Onset Postoperative Seizures in Patients With Diffuse Gliomas: A Risk Assessment Analysis

Mutation of isocitrate dehydrogenase gene in Chinese patients with glioma

Ki-67 overexpression in WHO grade II gliomas is associated with poor postoperative seizure control

1238 Next Generation Sequencing of Gliomas to Identify Predictors of Time to Postoperative Epilepsy

IDH1/2 Gene Hotspot Mutations in Central Nervous System Tumours: Analysis of 922 Chinese Patients

Seizure characteristics and outcomes in 508 Chinese adult patients undergoing primary resection of low-grade gliomas: a clinicopathological study.

Correlation of IDH1/2 Mutation with Clinicopathologic Factors and Prognosis in Anaplastic Gliomas: a Report of 203 Patients from China

Short-term Outcomes and Predictors of Post-Surgical Seizures in Patients with Supratentorial Low-Grade Gliomas.

Diagnostic and prognostic value of IDH1 mutation in gliomas

Molecular and clinical characterization of IDH associated immune signature in lower-grade gliomas

386 Seizure Presentation in IDH WT Glioma is Related to Upregulated Synaptic Signaling and Ionic Transport Genes

P89.07 A Large-Scale Survey of IDH1/2 Mutation in Chinese Patients with NSCLC

Surgically Treated Incidentally Discovered Low-Grade Gliomas Are Mostly Idh Mutated And 1p19q Co-Deleted With Favorable Prognosis

Association between accumulation of 2-hydroxyglutarate detected by MR spectroscopy and preoperative seizure in IDH-mutant glioma

Next Generation Sequencing Mutational Profiles of Gliomas Reveal Clinical and Genetic Factors Predicting Refractory Postoperative Seizures

IDH Mutations Occur Frequently in Chinese Glioma Patients and Predict Longer Survival but Not Response to Concomitant Chemoradiotherapy in Anaplastic Gliomas.

Predictors and Mechanisms of Epilepsy Occurrence in Cerebral Gliomas: What to Look for in Clinicopathology.